DAVID BATES to Hospital Costs
This is a "connection" page, showing publications DAVID BATES has written about Hospital Costs.
Connection Strength
1.157
-
An educational intervention to improve cost-effective care among medicine housestaff: a randomized controlled trial. Acad Med. 2012 Jun; 87(6):719-28.
Score: 0.362
-
The costs of adverse drug events in community hospitals. Jt Comm J Qual Patient Saf. 2012 Mar; 38(3):120-6.
Score: 0.356
-
The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997 Jan 22-29; 277(4):307-11.
Score: 0.124
-
A qualitative study identifying the cost categories associated with electronic health record implementation in the UK. J Am Med Inform Assoc. 2014 Oct; 21(e2):e226-31.
Score: 0.102
-
Improving safety and eliminating redundant tests: cutting costs in U.S. hospitals. Health Aff (Millwood). 2009 Sep-Oct; 28(5):1475-84.
Score: 0.075
-
Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis. 2001 Mar 01; 32(5):686-93.
Score: 0.041
-
Gender and utilization of ancillary services. J Gen Intern Med. 1998 Jul; 13(7):476-81.
Score: 0.035
-
Evaluation of screening criteria for adverse events in medical patients. Med Care. 1995 May; 33(5):452-62.
Score: 0.028
-
Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014 Jan; 9(1):12-20.
Score: 0.025
-
Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997 Aug; 25(8):1289-97.
Score: 0.008